Chemonucleolysis with chymopapain: results in 150 patients
1987 ◽
Vol 67
(2)
◽
pp. 187-191
◽
Keyword(s):
✓ Chemonucleolysis with chymopapain has been advocated for the treatment of lumbar disc disease. When polled by a mail questionnaire, 150 consecutive patients who had undergone chemonucleolysis reported an overall success rate of only 40% and a failure rate of 60%. However, 57% of the patients were active or had only mild restriction of daily activities. Of those patients employed prior to injection, only 63% had returned to work. Those with workmen's compensation benefits fared considerably worse than those covered by third-party insurance (17% vs. 51% success). These results cast doubt on the long-term benefits of chymopapain in the treatment of lumbar disc disease.
2018 ◽
Vol 12
(8)
◽
pp. 309-316
Keyword(s):
Keyword(s):
1982 ◽
Vol 56
(1)
◽
pp. 114-117
◽
Keyword(s):
2013 ◽
Vol 7
(1)
◽
pp. e1-e7
◽
Keyword(s):
Keyword(s):
1984 ◽
Vol 60
(1)
◽
pp. 183-186
◽
Keyword(s):
Keyword(s):
1986 ◽
Vol 64
(4)
◽
pp. 613-616
◽
Keyword(s):